In a paper in this month's PLoS Medicine, researchers from the Genome Institute of Singapore describe the identification of a human cellular protein that has a significant effect on the replication efficiency of Hepatitis B virus. Lisa F. P. Ng and colleagues found the protein--hnRNPK--when they noted an association between one particular sequence in the Hepatitis B virus and high levels of the virus in some infected patients. They discovered that how well the virus replicated is determined by a combination of sequence differences of the virus and how well hnRNPK binds to the viral DNA.

Hepatitis B is a serious global public health problem; more than 350 million people have lifelong infections. Chronically infected people are at high risk of death from cirrhosis of the liver and liver cancer, which both kill about 1 million people each year. Current antiviral therapies include lamivudine and alpha-interferon which also suppress viral replication by attacking the virus itself, but the identification of the action of this protein offers new therapeutic opportunities by targeting the human proteins that help the virus to replicate.

'"/>

Contact: Paul Ocampo
press@plos.org
415-624-1224
Public Library of Science
25-Jul-2005

Page: 1
Related biology news :

1. Identification of genetic risk factor for coeliac disease promises improved treatment
2. Identification of carbon dioxide receptors in insects may help fight infectious disease
3. Identification of specific genes predicts which patients will respond to Hepatitis C treatment
4. Penn researchers discover how key protein stops inflammation
5. UCF research links proteins, stem cells and potential Alzheimers treatment
6. Teamwork between 2 key proteins necessary for normal development and regulation of red blood cells
7. Discovery of new protein could provide new understanding of male fertility
8. Unlocking proteins from their cellular shell
9. Altering a protein makes mice less fearful
10. New research identifies anti-viral protein that may predict who might be at risk to develop lupus
11. MicroRNA works with Ago2 protein to regulate blood cell development